Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms

Journal of Cellular Biochemistry

Volumn 117, Issue 6, 2016, Pages 1396-1406

  Eleniste, Pierre P ^a   Patel, Vruti ^a   Posritong, Sumana ^a   Zero, Odette ^a   Largura, Heather ^a   Cheng, Ying Hua ^b   Himes, Evan R ^b   Hamilton, Matthew ^b   Baughman, Jenna ^b   Kacena, Melissa A ^b   Bruzzaniti, Angela ^a  

^a INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

ALKALINE PHOSPHATASE; BONE FORMATION; MINERALIZATION; PHOSPHORYLATION; TYROSINE KINASE

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; FOCAL ADHESION KINASE 2; MESSENGER RNA; MUTANT PROTEIN; OSTEOCALCIN; PHOSPHOPROTEIN; PTK2B PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; FETUS; MEGAKARYOCYTE; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; PHOSPHORYLATION;

ANIMALS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; FOCAL ADHESION KINASE 2; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; MEGAKARYOCYTES; MICE; OSTEOBLASTS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84962261839     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25430     Document Type: Article

References (47)

1. Allen JG, Lee MR, Han CY, Scherrer J, Flynn S, Boucher C, Zhao H, O'Connor AB, Roveto P, Bauer D, Graceffa R, Richards WG, Babij P,. 2009. Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells. Bioorg Med Chem Lett 19: 4924-4928.
2. Avraham H, Park SY, Schinkmann K, Avraham S,. 2000. RAFTK/Pyk2-mediated cellular signalling. Cell Signal 12: 123-133.
3. Avraham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE,. 1995. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem 270: 27742-27751.
4. Bruzzaniti A, Neff L, Sandoval A, Du L, Horne WC, Baron R,. 2009. Dynamin reduces Pyk2 Y402 phosphorylation and SRC binding in osteoclasts. Mol Cell Biol 29: 3644-3656.
5. Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, Bonnette PC, Baumann AP, Hambor JE, Grasser WA, III, Pan LC, Owen TA, Luzzio MJ, Hulford CA, Gebhard DF, Paralkar VM, Simmons HA, Kath JC, Roberts WG, Smock SL, Guzman-Perez A, Brown TA, Li M,. 2007. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc Natl Acad Sci USA 104 (25): 10619-10624.
6. Cheng YH, Hooker RA, Nguyen K, Gerard-O'Riley R, Waning DL, Chitteti BR, Meijome TE, Chua HL, Plett AP, Orschell CM, Srour EF, Mayo LD, Pavalko FM, Bruzzaniti A, Kacena MA,. 2013. Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation. J Bone Miner Res 28: 1434-1445.
7. Cheng YH, Streicher DA, Waning DL, Chitteti BR, Gerard-O'Riley R, Horowitz MC, Bidwell JP, Pavalko FM, Srour EF, Mayo LD, Kacena MA,. 2015. Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells. J Cell Physiol 230: 578-586.
8. Ciovacco WA, Cheng YH, Horowitz MC, Kacena MA,. 2010. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J Cell Biochem 109: 774-781.
9. Ciovacco WA, Goldberg CG, Taylor AF, Lemieux JM, Horowitz MC, Donahue HJ, Kacena MA,. 2009. The role of gap junctions in megakaryocyte-mediated osteoblast proliferation and differentiation. Bone 44: 80-86.
10. Delaisse JM,. 2014. The reversal phase of the bone-remodeling cycle: Cellular prerequisites for coupling resorption and formation. Bonekey Rep 3: 561.
11. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J,. 1996. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550.
12. Drachman JG, Sabath DF, Fox NE, Kaushansky K,. 1997. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 89: 483-492.
13. Ducy P, Schinke T, Karsenty G,. 2000. The osteoblast: A sophisticated fibroblast under central surveillance. Science 289: 1501-1504.
14. Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA,. 1998. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v) beta3 integrin, and phosphorylated by src kinase. J Clin Invest 102: 881-892.
15. Duong LT, Nakamura I, Lakkakorpi PT, Lipfert L, Bett AJ, Rodan GA,. 2001. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. J Biol Chem 276: 7484-7492.
16. Duong LT, Rodan GA,. 2000. PYK2 is an adhesion kinase in macrophages, localized in podosomes and activated by beta(2)-integrin ligation. Cell Motil Cytoskeleton 47: 174-188.
17. Eleniste PP, Bruzzaniti A,. 2012. Focal adhesion kinases in adhesion structures and disease. J Signal Transduct 2012: 296450.
18. Eleniste PP, Du L, Shivanna M, Bruzzaniti A,. 2012. Dynamin and PTP-PEST cooperatively regulate Pyk2 dephosphorylation in osteoclasts. Int J Biochem Cell Biol 44: 790-800.
19. Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL,. 2003. C-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. J Clin Invest 111: 749-758.
20. Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simoes MJ, Cerri PS,. 2015. Biology of bone tissue: Structure, function, and factors that influence bone cells. Biomed Res Int 2015: 421746.
21. Gil-Henn H, Destaing O, Sims NA, Aoki K, Alles N, Neff L, Sanjay A, Bruzzaniti A, De Camilli P, Baron R, Schlessinger J,. 2007. Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-/-) mice. J Cell Biol 178: 1053-1064.
22. Han S, Mistry A, Chang JS, Cunningham D, Griffor M, Bonnette PC, Wang H, Chrunyk BA, Aspnes GE, Walker DP, Brosius AD, Buckbinder L,. 2009. Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design. J Biol Chem 284: 13193-13201.
23. Horowitz MC, Fields A, DeMeo D, Qian HY, Bothwell AL, Trepman E,. 1994. Expression and regulation of Ly-6 differentiation antigens by murine osteoblasts. Endocrinology 135: 1032-1043.
24. Jilka RL, Cohn DV,. 1981. Role of phosphodiesterase in the parathormone-stimulated adenosine 3',5'-monophosphate response in bone cell populations enriched in osteoclasts and osteoblasts. Endocrinology 109: 743-747.
25. Kacena MA, Gundberg CM, Kacena WJ III, Landis WJ, Boskey AL, Bouxsein ML, Horowitz MC,. 2013. The effects of GATA-1 and NF-E2 deficiency on bone biomechanical, biochemical, and mineral properties. J Cell Physiol 228: 1594-1600.
26. Kacena MA, Eleniste PP, Cheng YH, Huang S, Shivanna M, Meijome TE, Mayo LD, Bruzzaniti A,. 2012. Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts. J Biol Chem. 287: 17257-17268.
27. Kacena MA, Gundberg CM, Nelson T, Horowitz MC,. 2005. Loss of the transcription factor p45 NF-E2 results in a developmental arrest of megakaryocyte differentiation and the onset of a high bone mass phenotype. Bone 36: 215-223.
28. Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, Horowitz MC,. 2006. Megakaryocyte-mediated inhibition of osteoclast development. Bone 39: 991-999.
29. Kacena MA, Shivdasani RA, Wilson K, Xi Y, Troiano N, Nazarian A, Gundberg CM, Bouxsein ML, Lorenzo JA, Horowitz MC,. 2004. Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF- E2. J Bone Miner Res 19: 652-660.
30. Kintscher U, Wakino S, Kim S, Fleck E, Hsueh WA, Law RE,. 2001. Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes. Hypertension 37: 587-593.
31. Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong lT,. 2003. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. Journal of Biological Chemistry 278: 11502-11512.
32. Lemieux JM, Horowitz MC, Kacena MA,. 2010. Involvement of integrins alpha(3)beta(1) and alpha(5)beta(1) and glycoprotein IIb in megakaryocyte-induced osteoblast proliferation. J Cell Biochem 109: 927-932.
33. Meijome TE, Hooker RA, Cheng Y-H, Walter W, Horowitz MC, Fuchs RK, Kacena MA,. 2015. GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. J Cell Physiol 230: 783-790.
34. Meyer AN, Gastwirt RF, Schlaepfer DD, Donoghue DJ,. 2004. The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation. J Biol Chem 279: 28450-28457.
35. Miyazaki T, Sanjay A, Neff L, Tanaka S, Horne WC, Baron R,. 2004. Src kinase activity is essential for osteoclast function. J Biol Chem 279: 17660-17666.
36. Ohmori T, Yatomi Y, Asazuma N, Satoh K, Ozaki Y,. 2000. Involvement of proline-rich tyrosine kinase 2 in platelet activation: Tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2. Biochem J 347: 561-569.
37. Park SY, Avraham HK, Avraham S,. 2004. RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner. J Biol Chem 279: 33315-33322.
38. Pfaff M, Jurdic P,. 2001. Podosomes in osteoclast-like cells: Structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin alphaVbeta3. J Cell Sci 114: 2775-2786.
39. Sanjay A, Houghton A, Neff L, DiDomenico E, Bardelay C, Antoine E, Levy J, Gailit J, Bowtell D, Horne WC, Baron R,. 2001. Cbl associates with Pyk2 and Src to regulate Src kinase activity, alpha(v) beta(3) integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152: 181-195.
40. Simmons DJ, Kent GN, Jilka RL, Scott DM, Fallon M, Cohn DV,. 1982. Formation of bone by isolated, cultured osteoblasts in millipore diffusion chambers. Calcif Tissue Int 34: 291-294.
41. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ,. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem 270: 9420-9428.
42. Tse KW, Lin KB, Dang-Lawson M, Guzman-Perez A, Aspnes GE, Buckbinder L, Gold MR,. 2012. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. Cell Immunol 275: 47-54.
43. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, Vainchenker W, Wendling F,. 1997. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90: 4369-4383.
44. Walker DP, Zawistoski MP, McGlynn MA, Li JC, Kung DW, Bonnette PC, Baumann A, Buckbinder L, Houser JA, Boer J, Mistry A, Han S, Xing L, Guzman-Perez A,. 2009. Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity. Bioorg Med Chem Lett 19: 3253-3258.
45. Wang Q, Xie Y, Du QS, Wu X, Feng X, Mei L, McDonald JM, Xiong W,. 2003. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J Cell Biol 160: 565-575.
46. Wong GL, Cohn DV,. 1975. Target cells in bone for parathormone and calcitonin are different: Enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc Natl Acad Sci USA 72: 3167-3171.
47. Zhang Z, Neff L, Bothwell AL, Baron R, Horne WC,. 2002. Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts. Bone 31: 359-365.